Global Compression Therapy Market is Expected to Reach $5.4 Billion by 2031: Says AMR

Portland, OR, March 22, 2023 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global Compression Therapy Market was valued at $3.2 billion in 2021 and is projected to reach $5.4 billion by 2031, registering a CAGR of 5.4% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4313               

Report coverage & details:

Covid-19 scenario-

• Compression therapy has proven to be an accurate and effective treatment for various vein conditions during the COVID-19 pandemic, providing valuable guidance for managing chronic diseases.
• The market happened to experience significant growth due to an increase in the number of deep vein thrombosis cases during the pandemic. The demand for compression therapy products also witnessed a sharp incline, as their effectiveness has been demonstrated in treating a range of medical conditions.

The global compression therapy market is analyzed on the basis of distribution channel, technique, application, and region. The study utilizes tabular and graphical representation to offer a thorough study of the segments and their sub-segments. The segmentation can assist investors and market participants to build strategies based on the top revenue-generating and fastest-growing segments identified by the study.

Procure Complete Report (400 Pages PDF with Insights, Charts, Tables, and Figures) @
https://www.alliedmarketresearch.com/checkout-final/compression-therapy-market

By distribution channel, the retail pharmacies segment contributed to the major share in 2021, garnering more than two-fifths of the global compression therapy market revenue. The e-commerce segment, on the other hand, would showcase the fastest CAGR of 6.0% during the forecast period.

By technique, the static compression therapy segment accounted for the highest share in 2021, generating nearly three-fifths of the global compression therapy market revenue. The dynamic compression therapy segment, however, would display the fastest CAGR of 5.6% throughout the forecast period.

By application, the varicose veins treatment segment held the highest share in 2021, garnering nearly two-fifths of the global compression therapy market revenue. The lymphedema treatment segment, simultaneously, would display the fastest CAGR of 6.1% throughout the forecast period.

By region, North America held the major share in 2021, accounting for around two-fifths of the global compression therapy market revenue. Asia-Pacific, simultaneously, is anticipated to grow at the fastest CAGR of 6.7% from 2022 to 2031. The other provinces studied through the report include Europe and LAMEA.

The key market players analyzed in the global compression therapy market report include Medtronic PLC, Bio Compression Systems, Inc., Medi GmbH and Co. K, Paul Hartmann AG, BSN Medical, Smith and Nephew PLC., 3M Company, Cardinal Health, Inc., Sanyleg S.R.L. and Sigvaris. These market players have adopted several strategies including new product development, clinical trials, product approval, branding, partnership, new product upgrade/ development, acquisition, expansion, strategic alliance, product launch, geographical expansion, collaboration, and agreement to highlight their expertise in the market. The report is helpful in formulating the business performance and developments by the top players.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

mHealth Market by Type (mHealth Devices and mHealth Services), Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers, and Content Players), and Application (Cardiovascular Diseases, Diabetes, Respiratory diseases, Neurological Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Oncology-Cancer Drugs Market By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), and Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Other Cancers): Opportunity Analysis and Industry Forecast, 2021-2030

Healthcare IT Market by Product Type (Healthcare Provider Solutions, Healthcare Payer Solutions, and HCIT Outsourcing Services), and End User (Healthcare Providers and Healthcare Payers): Global Opportunity Analysis and Industry Forecast, 2021-2030

In Vitro Diagnostics Market By Product And Services (Reagents, Instruments, Software And Services), by Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), by End User (Standalone Laboratories, Hospitals, Academic And Medical Schools, Point Of Care, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Animal Vaccines Market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines) and Animal Type (Companion Animal, Livestock Animal, and Aquaculture): Global Opportunity Analysis and Industry Forecast, 2021-2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.